Light-based treatment for early cervical changes
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and female
- You were diagnosed with CIN2 (cervical intraepithelial neoplasia grade 2) by biopsy within the last 3 months
- Your cervical lesion is visible on colposcopy and has not spread into the cervical canal
- You are not pregnant, do not plan to become pregnant during the study, and can use reliable contraception
- You have not had any prior treatment for this cervical condition
- You do not have certain medical conditions like severe immune problems, active infections, or a pacemaker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method using low-temperature argon plasma to treat cervical precancer (CIN 2) and compares it with the standard approach of active surveillance. If you have CIN 2 and are between 18 and 40 years old, this trial may offer an alternative to watching and waiting.
This study tests a light-based treatment (photodynamic therapy) for cervical precancer called CIN2. It may be an option if you want to avoid surgery and preserve the cervix.
This study tests a light-activated therapy (HAL-PDT) to treat high-grade cervical dysplasia before considering surgery. It compares the response to standard surgery, aiming to see if the light therapy can help avoid or delay more invasive procedures.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Hear when a new Cervical Intraepithelial Neoplasia Grade 2 (CIN2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.